🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multi-center center phase I/II study to establish the lowest possible ...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2023-06-05
Trial ID
NCT05123040
Treatments Being Tested
Our study aimed to determine the prophylactic value of ruxolitinib for aGVH...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05914714
Treatments Being Tested
The purpose of this study was to determine clinical efficacy and safety of ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00639002
Treatments Being Tested
The purpose of this study was to determine if ruxolitinib, in combination w...
Status
Terminated
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02119676
Treatments Being Tested
The participants are being asked to take part in this clinical trial becaus...
Status
Terminated
Location
St. Jude Children's Research Hospital
Start Date
2023-03-14
Trial ID
NCT05579769
This was a randomized, double-blind, placebo-controlled phase 2 clinical tr...
Status
Terminated
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT02120417
Treatments Being Tested
This is an open-label, dose-escalation study of the proviral integration si...
Status
Terminated
Location
The University of Arizona Cancer Center
Start Date
2015-12-29
Trial ID
NCT02587598
Treatments Being Tested
Steroid-refractory acute GVHD (srGVHD) is one of the causes of mortality af...
Status
Completed
Location
First Pavlov State Medical University of St. Petersburg
Start Date
2016-08
Trial ID
NCT02997280
Treatments Being Tested
To evaluate the safety and efficacy profile of different treatment regimens...
Status
Terminated
Location
Multiple Locations
Start Date
2008-08-20
Trial ID
NCT00726232
Treatments Being Tested
The purpose of the study is to assess the efficacy and safety of ruxolitini...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-09-09
Trial ID
NCT06824103
Treatments Being Tested